(BPRW) Bronzeville Summer Nights Series Returns

The U.S. Food and Drug Administration approved an HIV prevention medication that has been proven highly effective in clinical trials.Lenacapavir is an injectable treatment given twice a year to prevent HIV infection in adults and adolescents. In their June 17 announcement regarding FDA approval, Gilead Sciences, the drug’s manufacturer, stated that it will be marketed under the brand name Yeztugo.